CSPC Pharmaceutical Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	111,015	96,380	55,169	86,022	97,707	100,932
Market Cap Growth	102.75%	74.70%	-35.87%	-11.96%	-3.19%	6.47%
Enterprise Value	103,389	88,081	45,415	74,600	84,557	88,212
Last Close Price	9.71	8.43	4.65	6.73	7.30	7.35
PE Ratio	25.68	22.31	11.98	13.30	14.19	14.67
Forward PE	16.15	17.08	9.76	12.05	13.86	15.70
PS Ratio	3.84	3.33	1.79	2.48	2.79	2.95
PB Ratio	2.89	2.51	1.53	2.23	2.73	3.07
P/TBV Ratio	3.31	2.87	1.76	2.53	3.08	3.24
P/FCF Ratio	-	-	20.58	30.56	15.99	25.49
P/OCF Ratio	-	-	11.43	18.68	11.33	17.73
PEG Ratio	1.25	1.96	1.10	1.30	0.76	1.25
EV/Sales Ratio	3.57	3.04	1.47	2.15	2.42	2.58
EV/EBITDA Ratio	18.61	15.69	6.62	8.53	9.83	10.31
EV/EBIT Ratio	23.77	19.98	7.95	9.65	11.07	11.50
EV/FCF Ratio	-	-	16.94	26.50	13.83	22.27
Debt / Equity Ratio	0.02	0.02	0.02	0.02	0.02	0.00
Debt / EBITDA Ratio	0.13	0.13	0.08	0.09	0.08	0.01
Debt / FCF Ratio	-	-	0.20	0.28	0.11	0.03
Net Debt / Equity Ratio	-0.24	-0.24	-0.25	-0.37	-0.44	-0.42
Net Debt / EBITDA Ratio	-1.63	-1.63	-1.34	-1.65	-1.84	-1.61
Net Debt / FCF Ratio	-	-	-3.42	-5.11	-2.59	-3.47
Asset Turnover	0.57	0.57	0.64	0.71	0.81	0.86
Inventory Turnover	2.78	2.78	2.78	3.26	3.45	3.10
Quick Ratio	1.85	1.85	1.95	2.32	2.39	2.47
Current Ratio	2.19	2.19	2.27	2.63	2.67	2.81
Return on Equity (ROE)	11.33%	11.33%	12.60%	18.22%	21.32%	22.79%
Return on Assets (ROA)	5.44%	5.44%	7.40%	9.96%	11.04%	12.05%
Return on Invested Capital (ROIC)	12.29%	12.39%	17.69%	29.11%	33.40%	34.94%
Return on Capital Employed (ROCE)	10.80%	10.80%	15.40%	19.40%	20.60%	22.70%
Earnings Yield	3.89%	4.48%	8.35%	7.52%	7.05%	6.82%
FCF Yield	-	-	4.86%	3.27%	6.26%	3.92%
Dividend Yield	2.99%	3.44%	5.59%	4.22%	2.96%	2.54%
Payout Ratio	-	-	74.72%	46.42%	34.42%	30.16%
Buyback Yield / Dilution	2.68%	2.68%	1.14%	0.38%	0.29%	0.01%
Total Shareholder Return	5.66%	6.12%	6.73%	4.60%	3.25%	2.55%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.